DrugAug 21, 2019
Infusion Options Cisplatin 40 MG / 500 ml NS IVPB WITH Mannitol 40 G recall — FDA D-1760-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
10,685drug recall records
953FDA Class I records
8firms with 5+ records
Aidapak Services, LLC537 records
Database records
Records — page 169
10,685 detailed records are currently available in this category.
DrugAug 21, 2019
Infusion Options Gemcitabine 1910 MG / 250 ML NS IVPB recall — FDA D-1781-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
US Pharmaceuticals CRYO-273 Cold Pain Relieving Gel 128 FL recall — FDA D-1741-2019
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Class IIFDA: TerminatedUS Pharmaceuticals Inc.
DrugAug 21, 2019
US Pharmaceuticals Adult Glycerin Suppositories, Package Size 100-count suppositories recall — FDA D-1730-2019
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Class IIFDA: TerminatedUS Pharmaceuticals Inc.
DrugAug 21, 2019
US Pharmaceuticals Adult Glycerin Suppositories, Package Size 50-count suppositories recall — FDA D-1729-2019
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Class IIFDA: TerminatedUS Pharmaceuticals Inc.
DrugAug 21, 2019
Infusion Options LEUCOVORIN 560 MG / 250 ML NS IVPB recall — FDA D-1789-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
Infusion Options HERCEPTIN 400 MG / 250 ML NS IVPB recall — FDA D-1783-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
Infusion Options VELCADE 2.1 mg / 0.84 ml SQ SYRINGE recall — FDA D-1816-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
US Pharmaceuticals CRYO-273 Cold Pain Relieving Gel Roll-On 3 FL recall — FDA D-1737-2019
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Class IIFDA: TerminatedUS Pharmaceuticals Inc.
DrugAug 21, 2019
Infusion Options TRASTUZUMAB 427 MG / 250 ml NS IVPB recall — FDA D-1815-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
Infusion Options PACLITAXEL 258 MG / 500 ML NS IVPB recall — FDA D-1798-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
Infusion Options AVASTIN 630 MG / 100 ML 0.9% NACL IVPB recall — FDA D-1750-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
Infusion Options IRINOTECAN 250 MG /500 ml D5W IVPB recall — FDA D-1787-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
US Pharmaceuticals Cool Hot Ice Analgesic Gel, 8 oz (227 g) recall — FDA D-1738-2019
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Class IIFDA: TerminatedUS Pharmaceuticals Inc.
DrugAug 21, 2019
Infusion Options VINCRISTINE 1 MG /50 ML NS IVPB recall — FDA D-1818-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
Infusion Options Cytarabine 128 MG/250 ML D5W IVPB recall — FDA D-1762-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
Infusion Options Cyclophosphamide 840 MG / 250 ML NS IVPB recall — FDA D-1761-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
Infusion Options ADO-TRASTUZUMAB 210 MG/250 ml NS recall — FDA D-1747-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
US Pharmaceuticals Kool Comfort Cooling Pain Relief, 5% Menthol recall — FDA D-1739-2019
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Class IIFDA: TerminatedUS Pharmaceuticals Inc.
DrugAug 21, 2019
Infusion Options CARFILZOMIB 65 MG IN 50 ML D5W IVPB recall — FDA D-1757-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
Infusion Options PEMETREXED 910 MG QS 100 ML NS IVPB recall — FDA D-1803-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
Infusion Options BEVACIZUMAB 784 MG / 100 ML NS IVPB recall — FDA D-1752-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
Infusion Options Etoposide 184 MG / 500 ml NS IVPB recall — FDA D-1776-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
Infusion Options REMICADE 680 MG QS 250 ML 0.9% NACL IVPB recall — FDA D-1808-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
How to use this drug recall index
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
What the database can and cannot tell you
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.